EUVIMEDEUVIMED entdecken
Crossref

Herbal plant‐derived compound, 1,2,3,4,6‐penta‐ O ‐galloyl‐β‐ d ‐glucose, increases cross‐presentation by dendritic cells

Akiko Inujima, Miyuki Yamada, Nobuhiro Takeno, Akiko Hoshina, Mikihiro Oe, Kanna Shinohara, Naotoshi Shibahara, Hiroaki Sakurai, Ikuo Saiki, Keiichi Koizumi

Traditional & Kampo Medicine · 2015

DOI: 10.1002/tkm2.1017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Traditional & Kampo Medicine, 2015. Verfasst von Akiko Inujima und 9 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Institute of Natural Medicine, University of Toyama.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Vaccines have made great contributions to human welfare, and can be used even more effectively with adjuvants. The immune‐inducible effects of adjuvants are classified into four categories: T ‐helper ( Th )1, Th2 , antibody, and cytotoxic T ‐lymphocyte ( CTL ) responses. Exogenous antigens are mainly presented to major histocompatibility complex ( MHC ) class II molecules, but are also presented to MHC class I molecules via the antigen cross‐presentation process in dendritic cells. The enhancement of cross‐presentation of an injected vaccine antigen by an adjuvant leads to Th1 and CTL responses, resulting in successful intracellular infection and tumor vaccine therapy.

Methods

It is widely known that herbal medicines have strong immune response effects. With this in mind, we developed a novel vaccine adjuvant from natural compounds used in herbal medicine, through an in vitro model vaccine antigen (ovalbumin, OVA ) cross‐presentation assay.

Results

Among 89 natural compounds, 1,2,3,4,6‐penta‐ O ‐galloyl‐β‐ d ‐glucose ( PGG ) most enhanced cross‐presentation in dendritic cells. While the expression of MHC class II molecules was suppressed, PGG enhanced the expression of MHC class I molecules, restricted to OVA ‐derived peptides.

Conclusion

Restricted MHC class I expression resulting from the use of PGG enhanced cross‐presentation by dendritic cells.

Förderung

  • Institute of Natural Medicine, University of Toyama

Zitieren

APA

Inujima, A., Yamada, M., Takeno, N., Hoshina, A., Oe, M., Shinohara, K., Shibahara, N., Sakurai, H., Saiki, I., & Koizumi, K. (2015). Herbal plant‐derived compound, 1,2,3,4,6‐penta‐ O ‐galloyl‐β‐ d ‐glucose, increases cross‐presentation by dendritic cells. Traditional & Kampo Medicine. https://doi.org/10.1002/tkm2.1017

Vancouver

Inujima A, Yamada M, Takeno N, Hoshina A, Oe M, Shinohara K, et al. Herbal plant‐derived compound, 1,2,3,4,6‐penta‐ O ‐galloyl‐β‐ d ‐glucose, increases cross‐presentation by dendritic cells. Traditional & Kampo Medicine. 2015. doi:10.1002/tkm2.1017

BibTeX
@article{Inujima2015,
  author = {Inujima, Akiko and Yamada, Miyuki and Takeno, Nobuhiro and Hoshina, Akiko and Oe, Mikihiro and Shinohara, Kanna and Shibahara, Naotoshi and Sakurai, Hiroaki and Saiki, Ikuo and Koizumi, Keiichi},
  title = {Herbal plant‐derived compound, 1,2,3,4,6‐penta‐ O ‐galloyl‐β‐ d ‐glucose, increases cross‐presentation by dendritic cells},
  journal = {Traditional & Kampo Medicine},
  year = {2015},
  doi = {10.1002/tkm2.1017}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche